Literature DB >> 15509871

Application of locked nucleic acids to improve aptamer in vivo stability and targeting function.

Kathrin S Schmidt1, Sandra Borkowski, Jens Kurreck, Andrew W Stephens, Rolf Bald, Maren Hecht, Matthias Friebe, Ludger Dinkelborg, Volker A Erdmann.   

Abstract

Aptamers are powerful candidates for molecular imaging applications due to a number of attractive features, including rapid blood clearance and tumor penetration. We carried out structure-activity relationship (SAR) studies with the Tenascin-C binding aptamer TTA1, which is a promising candidate for application in tumor imaging with radioisotopes. The aim was to improve its in vivo stability and target binding. We investigated the effect of thermal stabilization of the presumed non-binding double-stranded stem region on binding affinity and resistance against nucleolytic degradation. To achieve maximal thermal stem stabilization melting experiments with model hexanucleotide duplexes consisting of unmodified RNA, 2'-O-methyl RNA (2'-OMe), 2'-Fluoro RNA (2'-F) or Locked Nucleic Acids (LNAs) were initially carried out. Extremely high melting temperatures have been found for an LNA/LNA duplex. TTA1 derivatives with LNA and 2'-OMe modifications within the non-binding stem have subsequently been synthesized. Especially, the LNA-modified TTA1 derivative exhibited significant stem stabilization and markedly improved plasma stability while maintaining its binding affinity to the target. In addition, higher tumor uptake and longer blood retention was found in tumor-bearing nude mice. Thus, our strategy to introduce LNA modifications after the selection procedure is likely to be generally applicable to improve the in vivo stability of aptamers without compromising their binding properties.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509871      PMCID: PMC528785          DOI: 10.1093/nar/gkh862

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  40 in total

1.  Tc-99m-labeling of modified RNA.

Authors:  C S Hilger; M C Willis; M Wolters; W A Pieken
Journal:  Nucleosides Nucleotides       Date:  1999 Jun-Jul

Review 2.  Aptamers: an emerging class of molecules that rival antibodies in diagnostics.

Authors:  S D Jayasena
Journal:  Clin Chem       Date:  1999-09       Impact factor: 8.327

3.  Potent and nontoxic antisense oligonucleotides containing locked nucleic acids.

Authors:  C Wahlestedt; P Salmi; L Good; J Kela; T Johnsson; T Hökfelt; C Broberger; F Porreca; J Lai; K Ren; M Ossipov; A Koshkin; N Jakobsen; J Skouv; H Oerum; M H Jacobsen; J Wengel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

4.  Developing aptamers into therapeutics.

Authors:  R R White; B A Sullenger; C P Rusconi
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

5.  Escort aptamers: a delivery service for diagnosis and therapy.

Authors:  B J Hicke; A W Stephens
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

6.  Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure.

Authors:  D H Mathews; J Sabina; M Zuker; D H Turner
Journal:  J Mol Biol       Date:  1999-05-21       Impact factor: 5.469

Review 7.  LNA-antisense rivals siRNA for gene silencing.

Authors:  Jan Stenvang Jepsen; Jesper Wengel
Journal:  Curr Opin Drug Discov Devel       Date:  2004-03

8.  General method to label antisense oligonucleotides with radioactive halogens for pharmacological and imaging studies.

Authors:  B Kühnast; F Dollé; S Terrazzino; B Rousseau; C Loc'h; F Vaufrey; F Hinnen; I Doignon; F Pillon; C David; C Crouzel; B Tavitian
Journal:  Bioconjug Chem       Date:  2000 Sep-Oct       Impact factor: 4.774

9.  Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor.

Authors:  D Jellinek; L S Green; C Bell; C K Lynott; N Gill; C Vargeese; G Kirschenheuter; D P McGee; P Abesinghe; W A Pieken
Journal:  Biochemistry       Date:  1995-09-12       Impact factor: 3.162

10.  The first analogues of LNA (locked nucleic acids): phosphorothioate-LNA and 2'-thio-LNA.

Authors:  R Kumar; S K Singh; A A Koshkin; V K Rajwanshi; M Meldgaard; J Wengel
Journal:  Bioorg Med Chem Lett       Date:  1998-08-18       Impact factor: 2.823

View more
  72 in total

1.  Development of DNA aptamers using Cell-SELEX.

Authors:  Kwame Sefah; Dihua Shangguan; Xiangling Xiong; Meghan B O'Donoghue; Weihong Tan
Journal:  Nat Protoc       Date:  2010-06-03       Impact factor: 13.491

2.  Utility of aptamer-fluorescence in situ hybridization for rapid detection of Pseudomonas aeruginosa.

Authors:  K-Y Wang; Y-L Zeng; X-Y Yang; W-B Li; X-P Lan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-10-10       Impact factor: 3.267

Review 3.  Nucleic acid aptamers: clinical applications and promising new horizons.

Authors:  X Ni; M Castanares; A Mukherjee; S E Lupold
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

4.  Expanding the concept of chemically programmable antibodies to RNA aptamers: chemically programmed biotherapeutics.

Authors:  Ulrich Wuellner; Julia I Gavrilyuk; Carlos F Barbas
Journal:  Angew Chem Int Ed Engl       Date:  2010-08-09       Impact factor: 15.336

5.  Circular Bivalent Aptamers Enable in Vivo Stability and Recognition.

Authors:  Hailan Kuai; Zilong Zhao; Liuting Mo; Hui Liu; Xiaoxiao Hu; Ting Fu; Xiaobing Zhang; Weihong Tan
Journal:  J Am Chem Soc       Date:  2017-06-29       Impact factor: 15.419

6.  Comparative crystallization and preliminary X-ray diffraction studies of locked nucleic acid and RNA stems of a tenascin C-binding aptamer.

Authors:  Charlotte Förster; Arnd B E Brauer; Svenja Brode; Kathrin S Schmidt; Markus Perbandt; Arne Meyer; Wojciech Rypniewski; Christian Betzel; Jens Kurreck; Jens P Fürste; Volker A Erdmann
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-06-10

7.  Aptamer-functionalized neural recording electrodes for the direct measurement of cocaine in vivo.

Authors:  I Mitch Taylor; Zhanhong Du; Emma T Bigelow; James R Eles; Anthony R Horner; Kasey A Catt; Stephen G Weber; Brian G Jamieson; X Tracy Cui
Journal:  J Mater Chem B       Date:  2017-03-06       Impact factor: 6.331

Review 8.  Aptamers and the next generation of diagnostic reagents.

Authors:  Varatharasa Thiviyanathan; David G Gorenstein
Journal:  Proteomics Clin Appl       Date:  2012-12       Impact factor: 3.494

Review 9.  In vitro selection of BNA (LNA) aptamers.

Authors:  Masayasu Kuwahara; Satoshi Obika
Journal:  Artif DNA PNA XNA       Date:  2013 Apr-Jun

10.  Cross-protection of influenza A virus infection by a DNA aptamer targeting the PA endonuclease domain.

Authors:  Shuofeng Yuan; Naru Zhang; Kailash Singh; Huiping Shuai; Hin Chu; Jie Zhou; Billy K C Chow; Bo-Jian Zheng
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.